Harnessing FAAH Inhibitors for Improved Clinical Outcomes

a adăugat un sunet Health

2026-01-21 17:10:01 - Translate -

The endocannabinoid system (ECS) has evolved from a field of academic interest into a major therapeutic area with significant commercial potential. However, the limitations of direct-acting cannabinoid agonists, particularly concerning safety and tolerability, have created a strategic gap in the market. This has prompted a decisive industry pivot towards a more sophisticated and druggable...

0 Commentarii 0 Distribuiri 414 Views 0 previzualizare